338 related articles for article (PubMed ID: 15764451)
1. Is the information "fair and balanced" in direct-to-consumer prescription drug websites?
Huh J; Cude BJ
J Health Commun; 2004; 9(6):529-40. PubMed ID: 15764451
[TBL] [Abstract][Full Text] [Related]
2. Direct-to-consumer prescription drug advertising.
Terzian TV
Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573
[No Abstract] [Full Text] [Related]
3. Pharmaceutical websites and the communication of risk information.
Davis JJ; Cross E; Crowley J
J Health Commun; 2007; 12(1):29-39. PubMed ID: 17365347
[TBL] [Abstract][Full Text] [Related]
4. A content analysis of direct-to-consumer television prescription drug advertisements.
Kaphingst KA; DeJong W; Rudd RE; Daltroy LH
J Health Commun; 2004; 9(6):515-28. PubMed ID: 15764450
[TBL] [Abstract][Full Text] [Related]
5. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
Hochhauser M
Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
[TBL] [Abstract][Full Text] [Related]
6. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
Rosenthal M
J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239
[No Abstract] [Full Text] [Related]
7. Trust in online prescription drug information among internet users: the impact on information search behavior after exposure to direct-to-consumer advertising.
Menon AM; Deshpande AD; Perri M; Zinkhan GM
Health Mark Q; 2002; 20(1):17-35. PubMed ID: 12749596
[TBL] [Abstract][Full Text] [Related]
8. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
Morgan S; Mintzes B; Barer M
J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759
[TBL] [Abstract][Full Text] [Related]
9. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television.
Macias W; Pashupati K; Lewis LS
Health Commun; 2007; 22(3):241-52. PubMed ID: 17967146
[TBL] [Abstract][Full Text] [Related]
10. Examining the FDA's oversight of direct-to-consumer advertising.
Gahart MT; Duhamel LM; Dievler A; Price R
Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
[TBL] [Abstract][Full Text] [Related]
11. A defense of the learned intermediary doctrine.
Goetz RB; Growdon KR
Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470
[No Abstract] [Full Text] [Related]
12. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
Hall TS
DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476
[No Abstract] [Full Text] [Related]
13. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
[TBL] [Abstract][Full Text] [Related]
14. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
Kopp SW; Bang HK
Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
[TBL] [Abstract][Full Text] [Related]
15. Regulation of prescription drug promotion: direct-to-consumer advertising.
Baylor-Henry M; Drezin NA
Clin Ther; 1998; 20 Suppl C():C86-95. PubMed ID: 9915094
[TBL] [Abstract][Full Text] [Related]
16. A prescription for better prescriptions.
Woosley RL
Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
[No Abstract] [Full Text] [Related]
17. New DTC guidelines please drug companies, anger critics.
Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080
[No Abstract] [Full Text] [Related]
18. The FDA's restrictions against prescription drug advertising: more hindrance than help.
Lorman AJ
Healthspan; 1991 Nov; 8(10):3-7. PubMed ID: 10114942
[No Abstract] [Full Text] [Related]
19. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
Kim H
Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
[TBL] [Abstract][Full Text] [Related]
20. [Communication and transparency concerning risk-benefit analysis in public health: the example of medication].
Lehner JP; Meyer F; Juillet Y
Therapie; 2001; 56(4):335-9. PubMed ID: 11677849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
